Article Information
History
- December 24, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Joseph Newman1,*,
- Nazia Thakur1,2,*,
- Thomas P. Peacock3,4,
- Dagmara Bialy1,
- Ahmed ME Elreafey1,
- Carlijn Bogaardt5,
- Daniel L. Horton5,
- Sammy Ho4,
- Thivya Kankeyan4,
- Christine Carr4,
- Katja Hoschler4,
- Wendy S. Barclay3,
- Gayatri Amirthalingam4,
- Kevin Brown4,
- Bryan Charleston1 and
- Dalan Bailey1,¥
- 1The Pirbright Institute, Guildford, Surrey, GU24 0NF, United Kingdom
- 2Nuffield Department of Medicine, The Jenner Institute, Oxford, OX3 7DQ, United Kingdom
- 3Department of Infectious Disease, Imperial College – London, W2 1PG, United Kingdom
- 4UK Health Security Agency (UKHSA), UK
- 5Department of Pathology and Infectious Diseases, School of Veterinary Medicine, University of Surrey
- ↵¥Corresponding author: dalan.bailey{at}pirbright.ac.uk
↵* These authors contributed equally to the work
Posted December 24, 2021.
Neutralising antibody activity against SARS-CoV-2 variants, including Omicron, in an elderly cohort vaccinated with BNT162b2
